Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 5,739 $ 6,830
Marketable debt securities 19,118 21,933
Restricted cash – security deposit 50 50
Prepaid expenses and other current assets 3,299 5,719
Total current assets 28,206 34,532
Non-current assets:    
Leasehold improvements and equipment – net 1,998 2,091
Operating lease right-of-use assets – net 3,480 3,613
Finance lease right-of-use assets – net 25 30
In-process research and development 3,017 3,017
Goodwill 1,336 1,336
Restricted cash – security deposit 200 200
Total non-current assets 10,056 10,287
Total assets 38,262 44,819
Current liabilities:    
Accounts payable 516 618
Accrued expenses 791 3,099
Operating lease liabilities – current 585 562
Financing lease liabilities – current 4 7
Total current liabilities 1,896 4,286
Non-current liabilities:    
Deferred tax liability 341 341
Operating lease liabilities – net of current portion 3,379 3,533
Financing lease liabilities – net of current portion 21 22
Total non-current liabilities 3,741 3,896
Total liabilities 5,637 8,182
Stockholders’ equity:    
Common stock par value $0.0001 per share, 500,000,000 shares authorized at March 31, 2023 and December 31, 2022; 217,264,526 issued and outstanding as of March 31, 2023 and December 31, 2022 22 22
Additional paid-in capital 191,342 190,070
Accumulated deficit (158,144) (152,631)
Accumulated other comprehensive loss (595) (824)
Total stockholders’ equity 32,625 36,637
Total liabilities and stockholders’ equity $ 38,262 $ 44,819